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Objective: Vital exhaustion is associated with the pathogenesis
of cardiovascular disease (CVD), but its prevalence after percuta-
neous coronary intervention (PCI) with drug-eluting stent implan-
tation, as well as the impact of personality on exhaustion, is not
known. In PCI patients, we examined (a) the prevalence of
exhaustion, (b) the impact of type-D personality on exhaustion
over time, and (c) the clinical significance of type-D personality
compared with gender and age as predictors of exhaustion.
Methods: Consecutive patients (n=419) with stable or unstable
angina treated with PCI with drug-eluting stent implantation
completed the Type-D Scale (DS14) at baseline and the Maastricht
Questionnaire (which assesses exhaustion) at baseline and at 1 year.
Results: Of all patients, 53% were exhausted at baseline and at
1 year, with 41% experiencing chronic symptoms. Type-D patients
[F(1, 417)=98.688; Pb.001] had significantly higher exhaustion
levels than non type-D patients both at the time of the index PCI0022-3999/06/$ – see front matter D 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.jpsychores.2006.12.015
4 Corresponding author. CoRPS, Department of Medical Psychology,
Room P503a, Tilburg University, Warandelaan 2, PO Box 90153, 5000 LE
Tilburg, The Netherlands. Tel.: +31 13 466 2503; fax: +31 13 466 2370.
E-mail address: s.s.pedersen@uvt.nl (S.S. Pedersen).and at 1 year. There was a general improvement in symptoms of
exhaustion over time [F(1, 417)=5.005; P=.03], but type-D
exerted a stable effect on exhaustion (P=.06). In multivariable
analysis, type-D (OR=3.53; 95% CI=1.88–6.64) remained an
independent predictor of exhaustion at 1 year, adjusting for
demographic and clinical risk factors and exhaustion at baseline.
The impact of type-D on exhaustion was large compared with a
small effect for gender and age, as measured by Cohen’s effect
size index. Conclusions: Symptoms of exhaustion were still
highly prevalent in PCI patients 1 year post-PCI despite treatment
with the latest technique in interventional cardiology. Type-D
exerted a large and stable effect on exhaustion compared with
that of gender and age. CVD research and clinical practice may
benefit by adopting a personality approach in order to identify
high-risk patients.
D 2007 Elsevier Inc. All rights reserved.Keywords: Cardiovascular disease; Drug-eluting stent; Revascularization; Type-D personality; Vital exhaustionIntroduction
Vital exhaustion is a mental state characterized by
unusual fatigue, demoralization, and increased irritability
[1]. Exhaustion is an etiological risk factor for ischemic heart
disease and all-cause mortality in healthy individuals [2] anda prognostic risk factor for adverse health outcomes in
patients following percutaneous coronary intervention (PCI)
and myocardial infarction (MI) [3–6]. The risk associated
with exhaustion in patients with established cardiovascular
disease (CVD) ranges from two- to three-fold [3,5], making it
a risk factor on par with traditional biomedical risk factors
[6,7]. Of note, exhaustion is not merely a marker of
subclinical CVD but a risk factor in its own right [3].
Symptoms of exhaustion have been linked to inflamma-
tion [8,9], cytomegalovirus, Chlamydia pneumoniae [9,10],
lower levels of cortisol and adrenocorticotropic hormones
[11,12], impaired fibrinolysis [13], and low vagal tone [14],earch 62 (2007) 447–453
Fig. 1. Flowchart of patient selection.
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CVD. Conceptually, exhaustion shares several features with
depression, and results are conflicting as to their independ-
ence [15,16]. Hence, this is the subject of an ongoing
debate. To fuel the debate, a recent study found that
exhaustion and self-rated health, but not depression, were
associated with increased inflammation in women with
CVD [17].
The recent Exhaustion Intervention Trial (EXIT) showed
that although symptoms of exhaustion were reduced by 55%
following a behavioral intervention, this benefit was only
seen in patients without a previous history of CVD [18].
Similarly, only patients without a previous history of CVD
experienced a 60% reduction in the risk of adverse health
outcomes, whereas the intervention did not lead to overall
enhanced survival at 2 years follow-up [18].
Although the EXIT increases our knowledge of factors
that may impede changes in exhaustion and subsequent
benefits to survival, little is known about the impact of
personality on exhaustion. Knowledge of the predictors of
exhaustion may lead to more successful intervention trials in
the future. In addition, focus on patient-centered outcomes,
such as exhaustion and its determinants, may bridge the gap
between research and clinical practice [19].
In a previous study conducted in the pre-drug-eluting
stent era, we identified type-D personality as a predictor of
exhaustion in a mixed group of cardiac patients pre- and
post-treatment with PCI, coronary artery bypass graft
(CABG) surgery, or conservative treatment [20]. Type-D
is defined as the tendency to experience increased negative
emotions paired with the non-expression of these emotions
in social interactions [21]. Type-D is an emerging risk factor
in CVD that has been associated with an increased risk of
adverse prognosis [22–26]. However, given that the use of
drug-eluting stents has been associated with a significant
decrease in the risk of restenosis and the need for repeat
revascularization [27] and that exhaustion plays a role in the
etiology of restenosis post-PCI, it is not clear whether
exhaustion remains a problem in the drug-eluting stent era.
The current study was conducted in a series of consec-
utive PCI patients treated with the paclitaxel-eluting stent
(PES) as the default stent. The aims were to (a) evaluate the
prevalence of symptoms of exhaustion, (b) examine the
impact of type-D personality on exhaustion at the time of
the index PCI and at 1 year, and (c) compare the clinical
significance of type-D personality with gender and age as
predictors of exhaustion.Materials and methods
Study design and participants
Consecutive patients with stable or unstable angina,
treated with PCI at the Erasmus Medical Center Rotterdam
using PES as the default strategy between July 1, 2003, andJuly 1, 2004, qualified for inclusion in the current study. Of
the 845 patients treated during this period, 19 patients died
within the first month and 116 were excluded due to
insufficient knowledge of the Dutch language. The remain-
ing 710 patients were approached and asked to complete a
number of psychological questionnaires 4 weeks post-PCI,
of whom 536 (75%) agreed. In the remainder of the article,
we will refer to this assessment as baseline. Although
assessment at 4 weeks was adapted for logistic reasons,
preliminary evidence suggests that psychological assess-
ment at the time of PCI may be less optimal than 1 month
post-procedure [28].
Given that we used a prospective design, analyses are
based on 419 patients, who had a score on the relevant
psychological questionnaires both at baseline and at follow-
up. See Fig. 1 for a flowchart of the patient selection for the
current study.
The study was approved by the local medical ethics
committee and conducted in accordance with the Helsinki
Declaration. Written informed consent was provided by
all patients.
Materials
Socio-demographic and clinical variables
Socio-demographic variables included gender and age.
Information on clinical variables, that is, indication for PCI
(stable or unstable angina), stent type (PES, sirolimus-
eluting stent, or other), multivessel disease, previous cardiac
history (i.e., MI, PCI, or CABG prior to the index PCI),
hypertension, dyslipidemia, diabetes mellitus, smoking, and
cardiac medication (aspirin, beta-blockers, diuretics, ACE
inhibitors, and statins), was obtained from the patients’
medical records.
Table 1






Males 79 (76) 235 (75) .88
Age, mean (S.D.) 62 (10) 63 (11) .30
Indication for PCI
Unstable angina 55 (53) 137 (44) .12
Stent type
PES 91 (88) 284 (90) .56
Clinical variables
Multivessel disease 58 (56) 193 (61) .38
Previous cardiac historya 55 (53) 174 (55) .76
Hypertension 51 (49) 151 (48) .94
Dyslipidemia 82 (79) 237 (75) .54
Diabetes mellitus 23 (22) 57 (18) .45
Current smoking 12 (12) 39 (12) .96
Cardiac medication
Aspirin 100 (96) 302 (96) 1.00
Beta-blockers 23 (22) 71 (23) 1.00
Diuretics 5 (5) 2 (1) .024
ACE inhibitors 13 (13) 25 (8) .23
Statins 74 (71) 239 (76) .41
Values are expressed as n (%) unless otherwise specified.
a MI, PCI, or CABG prior to the index PCI.
4 Pb.05.
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We used the Type-D Scale (DS14) to assess the
distressed (type-D) personality [21]. The scale consists of
14 items that are answered on a five-point Likert scale from
0 (false) to 4 (true). Seven items tap negative affectivity,
and seven items tap social inhibition (score range, 0–28 for
each subscale). Type-D caseness is defined by a high score
on both subscales, as determined by a standardized cut-off
score z10 [21]. The DS14 is a valid and reliable scale with
Cronbach’s a=.88/.86 and 3-month test–retest reliability
(r)=.72/.82 for the negative affectivity and social inhibition
subscales, respectively [21]. Type-D personality is more
than negative affect, as it also takes into account how
patients deal with this affect through the inclusion of the
social inhibition component [21,22]. The DS14 was
administered at baseline.
Vital exhaustion
The Maastricht Questionnaire (MQ) was used to assess
symptoms of exhaustion [1]. The questionnaire consists of
21 items that are answered on a three-point scale (0=no;
1=?; 2=yes), with a score range of 0–42. We used a
standardized cutoff score z14 to identify patients who were
exhausted [18,29]. The reliability of the scale, as measured
by Cronbach’s a, is .89 [1]. The MQ was administered both
at baseline and at 1 year post-PCI. Patients were asked to
complete the MQ items with regard to how they felt at the
time of completing the questionnaire; hence, answers were
not prone to recall bias.
Statistical analyses
Discrete variables were compared with the chi-square
test (Fisher’s exact test when appropriate), whereas
continuous variables were compared with Student’s t test
for independent samples. Analysis of variance (ANOVA)
for repeated measures was used to examine whether the
impact of type-D was stable over time. Univariable and
multivariable logistic regression analyses were used to
examine the impact of type-D personality on exhaustion at
1 year. Prior to analyses, we dichotomized vital exhaustion
using a standardized cutoff, with a score z14 indicating
those who are exhausted [18,28]. Exhaustion scores were
dichotomized to be able to compare results with previous
research and to enhance clinical interpretability, as advo-
cated by others [30,31]. In multivariable analyses, we
entered type-D personality, baseline exhaustion, gender,
age, indication for PCI, stent type, multivessel disease,
previous cardiac history (defined as MI, PCI, or CABG
prior to the index PCI), hypertension, dyslipidemia,
diabetes, and smoking. Cohen’s effect size index was used
to evaluate the clinical significance of type-D personality
compared with gender and age as predictors of exhaustion
[32]. An effect size of 0.20, 0.50, and z0.80 is considered
small, moderate, and large, respectively. We used a P value
b .05 to indicate statistical significance. Odds ratios (ORs)
with 95% confidence intervals (CIs) are reported.All statistical analyses were performed using SPSS 12.0.1
for Windows (SPSS, Chicago, IL, USA).Results
Differences between responders and non-responders on
baseline characteristics
Excluded patients and non-responders on psychological
questionnaires were more likely to smoke (22% vs. 14%;
P=.003) but less likely to suffer from dyslipidemia (63% vs.
74%; P=.001) than responders. No other differences
were found between excluded patients/non-responders
and responders on baseline characteristics, including
cardiac medication.
Patient baseline characteristics stratified by personality
Of the 419 patients, 104 (25%) had a type-D personality.
Baseline characteristics stratified by personality type are
shown in Table 1. Except for type-D patients being more
likely to be prescribed diuretics compared with non type-D
patients (5% vs. 1%; P=.02), no differences were found on
baseline characteristics between the two personality types.
Both at baseline and at 1 year post-PCI, 53% of the
patients were exhausted according to the predetermined cut-
off score z14. Of the 419 patients, 173 (41%) experienced
chronic symptoms, that is, a score z14 on the MQ both at
baseline and at 1 year. Exhaustion at 1 year could not be
Fig. 2. Exhaustion (mean scores) stratified by type-D personality at baseline
and at 1 year post-PCI. Mean scores (F standard deviations) are presented
on top of bars.
Table 2
Predictors of exhaustion at 1 year (multivariable analysis)
OR 95% CI P
Type-D personality 3.53 1.88–6.64 b.0014
Exhaustion at baseline 9.33 5.73–15.19 b.0014
Males 0.81 0.45–1.43 .46
Age 1.01 0.99–1.04 .39
Unstable angina 0.96 0.59–1.56 .86
PES 2.12 0.94–4.76 .07
Multivessel disease 0.97 0.58–1.62 .92
Previous cardiac historya 1.48 0.90–2.43 .13
Hypertension 0.66 0.40–1.10 .11
Dyslipidemia 0.72 0.41–1.28 .26
Diabetes mellitus 1.64 0.87–3.11 .13
Current smoking 0.78 0.36–1.69 .53
a Previous MI, PCI, or CABG.
4 Pb.001.
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follow-up (12% vs. 7%; P=.07).
Impact of type-D personality on exhaustion
As indicated in Fig. 2, ANOVA for repeated measures
showed that type-D patients [F(1, 417)=98.688; Pb.001]
had significantly higher mean exhaustion scores compared
with non type-D patients both at the time of the index PCI
and at 1 year. The within-subjects effect for time was also
significant [F(1, 417)=5.005; P=.03], indicating a general
decline in symptoms of exhaustion over time. The type-
Dtime interaction effect was not significant [F(1,
417)=3.702; P=.06], showing that type-D exerted a stable
effect on exhaustion over time.
Patients with chronic exhaustion, defined as exhaustion
both at baseline and at 1 year, were more likely to have a
type-D personality compared with patients with exhaustion
at either baseline or follow-up alone or exhaustion at neither
time points, with patients in the no-exhaustion group having
the lowest prevalence of type-D [v2(3, N=419)=58.822;
Pb.001] (Fig. 3).
In univariable analyses, type-D was associated with a
five-fold increased risk of exhaustion at 1 year post-PCI
(OR=5.53; 95% CI=3.23–9.45; Pb.001).
Independent predictors of exhaustion at 1 year
In multivariable analysis, type-D (OR=3.53; 95% CI=
1.88–6.64; Pb.001) remained an independent predictor ofFig. 3. Prevalence of type-D personality stratified by chronicity of
exhaustion.exhaustion at 1 year with a three-fold increased risk,
adjusting for demographic (gender and age) and clinical
risk factors (unstable angina, stent type, multi-vessel
disease, cardiac history, hypertension, dyslipidemia, diabe-
tes, and smoking) and exhaustion at baseline (Table 2).
Exhaustion at baseline (OR=9.33; 95% CI=5.73–15.19;
Pb.001) was also an independent predictor of exhaustion
at follow-up.
Clinical significance of type-D personality versus gender
and age
Given that gender and age are individual difference
variables routinely included in CVD research, we wanted to
evaluate the clinical significance of type-D compared with
gender and age z60 in relation to exhaustion, using Cohen’s
effect size index. We found that the effect of type-D on
symptoms of exhaustion was large both at baseline and at
1 year, whereas the effect of gender was small and that of
age was negligible at both time points (Fig. 4). In other
words, although the effects of gender, age, and type-D on
exhaustion were stable over the 1-year period, they had a
significantly differential effect on exhaustion.Fig. 4. Clinical relevance of type-D personality versus age and gender as
determinants of exhaustion at baseline and at 1 year.
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This is the first study to examine levels of exhaustion and
the impact of personality on exhaustion in PCI patients
treated in the drug-eluting stent era. The prevalence of
exhaustion at the time of the index procedure and at 1 year
was 53%, with 41% experiencing chronic symptoms. This
indicates that exhaustion is also highly prevalent in the
drug-eluting stent era. Patients with a type-D personality
experienced significantly higher levels of exhaustion both at
baseline and at 1 year, with type-D exerting a stable effect
over time. Type-D was also an independent predictor of
exhaustion 1 year post-PCI and was associated with a three-
fold increased risk, adjusting for demographic and clinical
baseline characteristics and exhaustion at baseline.
Despite treatment with PCI with drug-eluting stents, we
found that exhaustion is still highly prevalent, with 41%
being exhausted at both time points and, hence, experienc-
ing chronic, persistent exhaustion. This suggests that, once
present, exhaustion remains relatively stable and may not
abate with time. Similar prevalence rates have been found in
studies conducted in the pre-drug-eluting stent era in PCI
patients [29] and mixed cardiac patients [20]. In the latter
study, the prevalence of exhausted patients decreased from
75% at baseline to 59% following treatment [20]. However,
it should be noted that the baseline assessment took place
prior to PCI, CABG, or conservative treatment and that
these prevalences were point prevalence rates and do not
reflect levels of chronic symptoms.
Type-D personality was shown to exert a stable effect on
exhaustion during the 1-year follow-up period. In addition,
type-D was an independent predictor of exhaustion at 1 year
post-PCI, even when adjusting for demographic and clinical
characteristics and exhaustion at baseline, with the risk
being three-fold. This finding is at odds with a prospective
study on personality predictors of chronic fatigue in a
sample of working men and women, which found that the
impact of personality is negligible when adjusting for
baseline fatigue [33]. However, the latter study investigated
the impact of single personality traits rather than the
combination of traits, used fatigue as the outcome measure
rather than the broader construct of exhaustion, and was
conducted in a healthy population rather than in CVD
patients. In a previous study of a mixed group of cardiac
patients in the pre-drug-eluting stent era, we also found that
type-D personality was an independent predictor of exhaus-
tion at baseline and at follow-up, but in this study, we did
not adjust for baseline scores of exhaustion [20].
The results of the current study have implications for
research and clinical practice. Symptoms of exhaustion are
still highly prevalent in the drug-eluting stent era, with
future studies needing to investigate whether exhaustion is
also related to adverse clinical outcome in this era. More
importantly, these symptoms persisted over time, which
has also been shown by others, both in CVD patients
[18,20] and in a healthy sample [34]. Although the EXITtrial demonstrated that a behavioral intervention can
successfully alleviate symptoms of exhaustion leading to
improved prognosis, this benefit was only seen in patients
without a previous cardiac history [18]. In other words, we
still have no means by which to reduce exhaustion in
patients with a previous cardiac history and enhance their
survival, although several suggestions have been put
forward in a recent substudy of the EXIT trial that examined
the impact of the intervention on quality of life and other
secondary outcomes [35]. These suggestions comprise the
targeting of inhibition and hostility in future intervention
trials and to be aware of potential limiting factors, such as
chronic, painful comorbidities (e.g., rheumatism).
Future studies also need to examine the potential
interrelationship between exhaustion and depression.
Exhaustion and depression conceptually share several
features, and to date, results as to their independence have
been conflicting [15,16]. This knowledge is important to
reduce the burden to patients and for epidemiological
research, given the limited number of questionnaires that
can usually be included in a study design.
The current study pointed to type-D personality as an
important predictor of exhaustion, with type-D exerting a
stable and clinically significant effect compared with the
effect of gender and age. Gender and age are routinely
included in CVD research, whereas, to a large extent, a
personality approach has been abandoned since inconsistent
results in relation to the type-A Behavior Pattern were
reported [36]. The findings of the current study and other
studies [23–26] indicate that a personality approach may be
advantageous in terms of identifying high-risk patients.
However, the ensuing question is that if type-D personality
is an all-important predictor of exhaustion, how do we
modify its impact on exhaustion and other health outcomes?
Undoubtedly, it will be important to teach type-D patients to
cope with stress in a different way, which can be done by
means of a combination of cognitive behavioral therapy,
psychotherapy, and relaxation therapy. However, designing
an intervention trial targeting type-D at this point in time is
somewhat premature, as we know very little about the
moderators and mechanisms that may relate type-D to
adverse health outcome, be they physiological or behavioral
or a combination thereof. In other words, attention should
now be focused on research into these moderators and
mechanisms, which may, on the long term, lead to the
designing of more successful intervention trials.
The results of the current study should be interpreted
with some caution. First, the response rate was 75%, with
non-responders/excluded patients being more likely to
smoke but less likely to suffer from dyslipidemia than
responders. Second, we only included patients with stable or
unstable angina, and the results may not generalize to
patients, who had an acute MI as indication for PCI.
Nevertheless, the studying of patients with angina is
important since psychosocial factors have also been shown
to predict mortality in these patients [37]. Third, we had no
S.S. Pedersen et al. / Journal of Psychosomatic Research 62 (2007) 447–453452information on participation in cardiac rehabilitation and the
use of psychotropic medication, such as antidepressants,
which could potentially influence levels of exhaustion.
Fourth, there is evidence to suggest that the Maastricht
Interview for Vital Exhaustion may have better predictive
validity concerning future cardiac events than the self-report
MQ [38], which was used in the current study. However, the
MQ has also been shown to predict future adverse clinical
events [3,5] and is a more feasible instrument to use in
clinical research and practice. An advantage of the current
study was its prospective design with the assessment of
exhaustion at two time points.
In conclusion, the results of the current study show that
exhaustion is still highly prevalent in PCI patients treated in
the drug-eluting stent era and that symptoms remain
relatively stable over a 1-year period. Type-D personality
exerted a three-fold increased risk even when adjusting for
baseline exhaustion in addition to demographic and clinical
characteristics. When comparing the clinical relevance of
type-D with gender and age, two characteristics that are
routinely included in CVD research, a large effect was
found for type-D, whereas small effects were found for
gender and age. CVD research and clinical practice may
benefit by adopting a personality approach in order to
identify high-risk patients.Acknowledgments
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